A prospective study sought to determine the value of geriatric assessment in patients with non-Hodgkin lymphoma, compared with assessment based on chronological age.
Researchers conducted a secondary analysis of data from the phase 3 LY.12 clinical trial to measure effect of frailty on outcomes for patients with lymphoma.